Quote this publication Share Print


Opinions on drugs - Posted on Feb 10 2014

Reason for request

Extension of indication


Clinical Benefit


Substantial in type 1 diabetes in children aged 2 to 5 years.

Clinical Added Value

no clinical added value

LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes.